疑似原发性甲状旁腺功能亢进患者乳糜泻评估频率及对临床结局的影响
单中心横断面研究纳入2415例疑似散发性原发性甲状旁腺功能亢进患者,仅11%术前接受乳糜泻抗体检测,6%抗体阳性,2例确诊乳糜泻。乳糜泻诊断与治疗可能有助于识别原发性甲状旁腺功能亢进,对血钙正常而PTH升高者应考虑评估。
要点
- 疑似原发性甲旁亢患者中乳糜泻评估率低,仅11%接受抗体检测。
- 接受评估者多腺体病变患病率更高(38% vs 30%,P=.01)。
- 血钙正常而PTH升高者应考虑乳糜泻评估以助鉴别。
核心结论
- 乳糜泻在疑似原发性甲状旁腺功能亢进患者中诊断率低,但诊断和治疗乳糜泻可能有助于识别原发性甲状旁腺功能亢进。
研究设计与样本
- 单中心横断面研究纳入2010年1月1日至2024年7月1日因疑似散发性原发性甲状旁腺功能亢进接受初次甲状旁腺切除术评估的成年患者2415例,80%为女性,中位年龄64岁(55,70)。
主要发现
- 2415例中266例(11%)接受乳糜泻评估,其中15例(6%)乳糜泻抗体阳性,2例确诊乳糜泻并在乳糜泻治疗后识别出原发性甲状旁腺功能亢进。
- 接受乳糜泻评估者女性更多(88% vs 78%,P<.005)、年龄更大(中位65岁[55,73] vs 63岁[55,70],P=.04)、高血清钙比例更低(97% vs 99%,P<.005)、多腺体病变患病率更高(38% vs 30%,P=.01),术后持续性病变患病率相似(3% vs 2%,P=.38)。
- 共2137例(89%)接受甲状旁腺切除术,未手术者中接受乳糜泻评估的比例更高(18% vs 10%,P<.005)。
临床怎么用
- 对疑似原发性甲状旁腺功能亢进患者,尤其表现为血钙正常而PTH升高时,应考虑进行乳糜泻评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with primary hyperparathyroidism and secondary hyperparathyroidism due to celiac disease may both present with high parathyroid hormone and normal calcium levels, but their management differs. This study aimed to assess the frequency of celiac disease evaluation among patients with presumed primary hyperparathyroidism and characterize the impact of preoperative evaluation among patients undergoing parathyroidectomy. METHODS: A single-institution cross-sectional study of adult patients evaluated for initial parathyroidectomy for presumed sporadic primary hyperparathyroidism from January 1, 2010, to July 1, 2024, was completed. All patients were assessed for preoperative celiac disease antibody testing. Among those who underwent parathyroidectomy, preoperative biochemical profiles, prevalence of multigland disease, and persistent disease were compared by celiac disease evaluation status. RESULTS: Of 2,415 patients (80% female, median age 64 years [55, 70]), 266 (11%) were evaluated for celiac disease, of whom 15 (6%) had positive celiac disease antibodies. Two of 15 patients were confirmed to have celiac disease, in whom primary hyperparathyroidism was recognized after celiac disease treatment. Patients evaluated for celiac disease were more likely female (88% vs 78%, P < .005) and older (median age 65 years [55, 73] vs 63 years [55, 70], P = .04), less frequently presented with high serum calcium (97% vs 99%, P < .005), had higher prevalence of multigland disease (38% vs 30%, P = .01), and similar prevalence of postoperative persistent disease (3% vs 2%, P = .38) compared with those not evaluated. Overall, 2,137 (89%) underwent parathyroidectomy. Patients managed nonoperatively were more frequently evaluated for celiac disease (10% vs 18%, P < .005). CONCLUSIONS: Celiac disease is infrequently diagnosed in patients with presumed primary hyperparathyroidism. Celiac disease diagnosis and treatment may facilitate recognition of primary hyperparathyroidism and should be considered in patients presenting with normocalcemia and high parathyroid hormone.
引用
- Lisevick AB, Dream S, Yen TWF, et al. Frequency of evaluation of celiac disease in patients with presumed primary hyperparathyroidism and impact on clinical outcomes. Surgery. 2025. PMID: 40505194. doi:10.1016/j.surg.2025.109488
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。